# Optimal-strategy-and-benefit-of-non-continuous-therapy
Codes and raw data for paper titled "Optimal strategy and benefit of non-continuous therapy depend on tumor heterogeneity and aggressiveness at the time of diagnosis"<br>
<ul>
Data files included in the repository:<br>
<ul>
  <li>Fig1andSuppFig1-2/1drugsimulationdata_paper.csv</li>
  <li>Fig2andSuppFig3/2drugsimulationdata_paper.csv</li>
  <li>Fig3andSuppFig4/Euler2drugsim.csv</li>		
  <li>Fig3andSuppFig4/Euler1drugsim.csv</li>	
  <li>Fig4andSuppFig5-7/tumormarkers_paper.csv</li>
  <li>Fig4andSuppFig5-7/treatmentdata_paper.csv</li>
  <li>Fig4andSuppFig5-7/treatmenttable_paper.csv</li>
</ul>
